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Abstract
In 2012 and 2013, influenza virus genome sequences of two new influenza A virus (IAV) subtypes were discovered in bat
specimens, but further characterization was largely impeded by the lack of infectious virus. With the identification of highly
susceptible cell lines, reconstitution of infectious bat IAV by reverse genetics recently succeeded and allowed a first insight
into the life cycle of these viruses. Although there is a certain degree of functional compatibility between bat and
conventional influenza A virus proteins, there are striking differences, including receptor usage, polarity of infection and
reassortment potential.
INTRODUCTION
Influenza A viruses (IAVs) are the causative pathogens of
annual epidemics and sporadically occurring pandemics
responsible for substantial morbidity and mortality in the
human population [1]. The main antigenic determinants
of IAV are the surface glycoproteins haemagglutinin (HA)
and neuraminidase (NA). Based on the gene homology
and antigenic properties of HA and NA, IAVs have been
classically subdivided into 16 different HA (H1 to H16)
and nine different NA subtypes (N1 to N9) [2]. All known
IAV subtypes have been found in aquatic waterfowl, which
is therefore thought to represent the natural IAV reservoir
[3]. Nevertheless, avian IAVs (AIVs) have recurrently
crossed species barriers thereby establishing new lineages
in a wide variety of hosts, including sea mammals, domes-
tic animals such as pigs and horses, domestic poultry, and
humans [3]. Here, migrating aquatic birds are of particular
importance for the emergence and evolution of novel
influenza viruses with zoonotic potential, since they carry
all known IAV subtypes and can disseminate AIV over
long distances [3, 4]. Currently, the IAV subtypes H1N1
and H3N2 are circulating within the human population,
causing annual epidemics. However, there is some concern
that AIV subtypes such as H5N1 and H7N9 may adapt to
the human species [5, 6]. Since the human population is
immunologically naïve with respect to these ‘foreign’ HA
subtypes, successful establishment of a new lineage in the
human population may eventually result in a pandemic
associated with high mortality and morbidity. Further-
more, as IAV is a segmented negative-strand RNA virus,
co-infection of pigs with avian, human and/or porcine
IAV could lead to the emergence of new IAVs harbouring
a novel constellation of the eight genome segments [7–10].
These so-called reassortant viruses have a high zoonotic
potential, as recently exemplified by the 2009 pandemic
H1N1 virus [7].
The previous understanding of the IAV host range and
diversity has recently been challenged by the discovery of
two novel influenza subtypes in Central and South
American bat species. In 2012, a new influenza virus
genomic sequence was identified in frugivorous yellow-
shouldered bats (Sturnira lilium) in Guatemala and provi-
sionally designated as H17N10 [11]. Only one year later,
a distinct influenza genome was isolated from the flat-
faced fruit bat (Artibeus planirostris) in Peru and initially
classified as H18N11 [12]. Serological surveys in Central
and South American bat populations revealed a broad
prevalence of H17/H18-specific antibodies [12], suggesting
a widespread circulation of these viruses in different bat
species. Unfortunately, isolation of infectious virus from
various bat tissues failed, greatly impeding further charac-
terization of these new IAV subtypes. However, phyloge-
netic analysis of these bat-derived influenza virus
genomes indicated that most genes were most closely
related to those of conventional IAV [11, 12]. Notable
exceptions were the putative bat-derived HA and NA
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genes, which showed only low homology with their coun-
terparts from other IAVs. As outlined below in detail,
biochemical data have convincingly demonstrated that the
surface glycoproteins of both H17N10 and H18N11 are
strikingly different from conventional IAV since they lack
the canonical receptor-binding and receptor-destroying
activities of conventional HA and NA, respectively [12–
16]. Based on these marked differences, we suggested
renaming the bat IAV surface glycoproteins as HA-like
(HL) and NA-like (NL) [17].
The identification of bat IAV expanded the host reservoir of
IAV and immediately raised the question of their zoonotic
potential. Only recently, it became possible to reconstruct
infectious bat IAV from synthetic DNA using reverse
genetic approaches [18]. In this review, we recapitulate
recent findings on cell tropism, entry processes and the abil-
ity of these bat IAVs to exchange genetic information with
conventional IAV.
BAT IAVS FAIL TO REASSORT WITH
CONVENTIONAL IAVS
The IAV genome comprises eight single-stranded viral
RNA (vRNA) segments in negative polarity, each encapsi-
dated by multiple copies of the viral nucleoprotein (NP)
and terminally bound by the viral RNA polymerase, form-
ing the viral ribonucleoprotein (vRNP) complex [19–22].
All vRNA segments share a similar structure in that they
encompass a central coding region, flanked on both sides
by short non-coding regions (NCR). Located at the
extreme 3¢ and 5¢ genome ends, 12 and 13 nucleotide-long
complementary sequences are highly conserved between
different IAV segments and serve as promoters for the
viral polymerase [23–26]. In cells co-infected with different
parental IAVs, exchange of viral genome segments can
give rise to IAV with a new genetic composition, a process
called reassortment [7, 9, 10, 27]. The exchange of genome
segments between IAVs allows rapid adaption to new host
environments and is known to be responsible for the
emergence of several pandemic IAV strains in the past [7,
8]. An important prerequisite for genetic reassortment is
the functional compatibility of the parental viral proteins
[28]. However, segmentation of the viral genome concur-
rently complicates vRNP packaging as it demands a highly
sophisticated mechanism that coordinates the selective
packaging of the eight distinct vRNPs into viral progeny
particles [23]. Although the precise mechanism of IAV
genome packaging into progeny virions has not been con-
clusively clarified yet, there is considerable evidence that
each vRNA segment bears so-called packaging signals
within the 3¢ and 5¢ NCR together with adjacent parts of
the vRNA coding region [29]. It is believed that the pack-
aging signals mediate the formation of a bundle of eight
different vRNPs by forming RNA–RNA or RNA–protein
interaction networks [30–33].
Bat IAVs exhibit the characteristic genome structure of con-
ventional IAVs. They are composed of eight vRNA
segments in anti-sense orientation including terminal
NCRs. Likewise, the highly conserved complementary pro-
moter sequences comprising 12 and 13 nucleotides at the
extreme 3¢ and 5¢ ends of each bat genome segment are
almost identical to those found in conventional IAVs [11,
12]. Moreover, with the exception of the envelope glycopro-
tein homologues HA, NA and M2, the amino acid sequen-
ces of the remaining bat virus proteins are akin to known
IAV proteins reaching 50–80% identity, depending on the
protein sequence analysed. To determine the reassortment
potential between bat and conventional IAV, chimeric bat
viruses were engineered containing six bat gene segments
from either HL17NL10 or HL18NL11 virus, along with the
IAV HA and NA genes from the prototypic IAVs A/Puerto
Rico/8/1934 (H1N1) (PR8), A/swine/Texas/4199-2/1998
(H3N2) or A/SC35M (H7N7) [34, 35]. These chimeric
viruses were shown to efficiently replicate in various cell
culture models and in mice. Of note, generation of these bat
chimeric viruses by reverse genetics was only possible if the
HA and NA coding regions were flanked with the authentic
bat IAV NCR and parts of the coding region of the corre-
sponding segment, already suggesting genome-packaging
incompatibilities between bat influenza RNA segments and
those of conventional IAV [34, 35]. Indeed, co-infection
experiments confirmed that bat chimeric viruses failed to
reassort with the conventional IAV subtypes H1N1, H3N2
and H7N7. However, gene reassortment was observed after
co-infection with both HL17NL10- and HL18NL11-based
bat chimeric viruses (Fig. 1a) [35]. In contrast to co-infec-
tion experiments, reverse genetics rescue experiments using
the eight genome segments resulted in a significant higher
number of reassortment events, since competition of
homologous vRNA segments from different viruses for
genome packaging was avoided. This might also explain the
successful generation of recombinant HL17NL10-based bat
chimeric reassortant viruses harbouring the HA and NA
surface protein genes of PR8 plus an unmodified M segment
from either PR8, A/swine/Texas/4199-2/98 (H3N2) or A/
swine/Kansas/11-107824/2011 (H3N2) [36]. These reassor-
tant viruses replicated efficiently in various cell lines and in
the lungs of infected mice. Based on these findings, it is
likely that the M segment packaging signals are at least par-
tially compatible between bat and conventional IAV. How-
ever, the failure of bat chimeric viruses to reassort with
conventional IAV was also partly due to an incompatibility
between the internal proteins. Whereas NP of bat virus ori-
gin, and to a certain degree also the polymerase subunit
PB2, supported the polymerase activity of the H1N1, H2N2,
H3N2, H5N1 and H7N9 subtypes in polymerase reconstitu-
tion assays, PB1 and PA did not [34, 35, 37]. In addition, as
the bat IAV non-structural protein 1 (NS1) was previously
shown to share the dsRNA-binding property and IFN-sup-
pression characteristics of conventional IAV NS1s [38], an
infectious recombinant PR8 virus encoding the NS1 but not
NEP gene of HL17NL10 could be generated [39]. Thus, the
combination of both incompatible packaging sequences and
incompatible viral proteins has likely contributed to the
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failure to exchange genetic information between bat and
conventional IAVs.
Surprisingly, although NP of bat IAV fully supported the
polymerase activity of conventional IAV of various sub-
types, including H7N7, in a polymerase reconstitution
assay, the generation of recombinant H7N7 viruses encod-
ing bat IAV NP repeatedly failed, despite flanking the bat
IAV NP coding region with authentic packaging sequen-
ces. However, partial substitution of H7N7 NP amino acid
residues with the corresponding ones from HL17NL10 NP
was tolerated and allowed the generation of viable H7N7
NP mutant viruses. Unexpectedly, these NP amino acid
substitutions caused impaired viral infectivity due to an
uncoordinated packaging of genomic segments into viral
particles [40]. Mutational studies further revealed that as
few as seven amino acid substitutions are sufficient to
cause these packaging defects. Depending on whether the
highly conserved H7N7 NP amino acids of the head or
the body domain had been substituted with bat IAV
amino acids (Fig. 1b), the incorporation of specific RNA
genome segment subsets was differentially affected
(Fig. 1c) [40]. This is the first indication that a viral pro-
tein can specifically recognize vRNA packaging signals,
suggesting a complex interplay between NP and the
vRNA packaging signals. Therefore, the lack of reassort-
ment between bat and conventional IAV can be ascribed
to the incompatibility of the vRNA packaging signals and
NP. The vRNA packaging signals and the NP proteins of
Fig. 1. Co-infection of cells with bat and conventional influenza A viruses does not result in reassortment events. (a) The exchange of
genomic segments is known to take place in cells co-infected with different conventional IAV subtypes. Likewise, based on experiments
with chimeric bat influenza viruses, genomic reassortment is believed to occur in cells co-infected with the known bat IAV subtypes.
However, reassortment between conventional and bat IAVs is blocked, probably due to incompatibility of the vRNA packaging signals
and NP. (b and c) Highly conserved amino acids located in either the head (grey) or body (black) domain of a conventional IAV NP of
the H7N7 subtype (A/SC35M) were partially substituted with the corresponding amino acids present in the HL17NL10 NP (b). Bat-spe-
cific amino acids introduced in the head or body domain are highlighted in pink or yellow, respectively. H7N7 viruses encoding these
NP mutants demonstrated a genome packaging deficiency (c). The incorporation of different RNA segment subsets into viral particles
was differentially affected, depending on whether the mutations were introduced into the head or body domain. The relative ratio of
genome subsets identified in viral particle preparations is shown (raw data from Moreira et al. [40]). Genome levels of wild-type (WT)
H7N7 were set to 1. Column colours correspond to the amino acid substitutions in either the head or body domain.
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bat and conventional IAV might have evolved differen-
tially in their respective hosts and probably have under-
gone co-evolutionary adaptation resulting in an optimal
interaction of the eight distinct vRNPs during the genome
packaging process. Hence, reassortment of the newly dis-
covered HL17NL10 and HL18NL11 subtypes with conven-
tional IAV and emergence of pandemic reassortant viruses
seems rather unlikely.
RECONSTITUTION OF AUTHENTIC BAT IAV BY
REVERSE GENETICS
The initial failure to generate infectious bat IAVs from
synthetic DNA by reverse genetics was suspected to be
related to the use of non-susceptible cell lines. This
problem has recently been overcome by using vesicular
stomatitis virus (VSV) encoding either HL-17 or HL-18
(VSV-HL) in place of the VSV-G protein [18]. Screening
of more than 30 cell lines from various species using these
chimeric viruses led to the identification of Madin–Darby
canine kidney type II (MDCK II) cells as being most sus-
ceptible, whereas the related MDCK I cell line turned out
to be resistant to infection. In agreement with this observa-
tion, both recombinant HL17NL10 and HL18NL11 could
be successfully propagated in MDCK II but not MDCK I
cells. However, both MDCK cell types, which originated
from the kidney of the same dog but differed in their pas-
sage history, are well known to support viral growth of
conventional IAV. Subsequent studies with both chimeric
VSV and recombinant HL18NL11 revealed differences in
the entry mechanism compared to conventional IAV. In
polarized MDCK II cells, infection by HL18NL11 was initi-
ated most efficiently from the basolateral site (Fig. 2), a
property that is shared by other viruses including VSV,
hepatitis B virus, hepatitis C virus, adenovirus types 2 and
5, vaccinia virus and measles virus [41–46]. In contrast,
conventional IAVs are known to enter polarized epithelial
cells via the apical site of the plasma membrane [47]. The
preferential basolateral infection of polarized epithelial cells
by bat IAV suggests that the putative cellular receptor(s)
for these viruses are preferentially expressed at the basolat-
eral membrane but absent from the apical plasma mem-
brane of MDCK II cells. At least two human cell lines,
U-87 MG glioblastoma and SK-Mel-28 malignant mela-
noma cells, were found to be susceptible to infection with
VSV-HL17 and VSV-HL18 as well as with authentic
HL17NL10 and HL18NL11 [18]. However, whether this
already indicates a zoonotic potential of bat IAVs remains
to be shown. Surprisingly, recombinant bat IAVs were
unable to infect cell lines from various bat species, includ-
ing Sturnira lilium and Artibeus planirostris, which are
believed to be naturally infected by these viruses (unpub-
lished data). The reason for this unexpected resistance is
unknown, but might be caused by the downregulation of
the virus entry receptor(s) upon in vitro culturing of the
bat cells. This was previously described for bat coronavi-
ruses, where susceptibility or resistance of bat cell lines
correlated with the presence or absence of the cell surface-
expressed receptor CD26, also known as dipeptidyl pepti-
dase 4 (DPP4) [48].
Fig. 2. Bat and conventional IAVs exhibit different entry mechanisms in polarized epithelial cells. Conventional IAVs initiate the infec-
tion at the apical site of epithelial cells by receptor-mediated endocytosis after the binding of HA to sialic acid containing oligosacchar-
ides exposed on the host cell surface. Following completion of the IAV replication cycle, progeny virions are then released from the
apical plasma membrane where NA facilitates the cleavage of sialic acid residues. In contrast, bat IAVs enter polarized epithelial cells
preferentially from the basolateral site via endocytosis upon binding of HL to a yet unknown receptor. Budding of progeny bat IAV viri-
ons occurs similarly to conventional IAV at the apical plasma membrane.
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HAEMAGGLUTININ-LIKE MOLECULES PLAY
CRUCIAL ROLES IN BAT IAV ENTRY
Based on the analysis of the primary sequences, classical
HA molecules are categorized into two phylogenetic
groups, with group 1 comprising subtypes H1, H2, H5, H6,
H8, H9, H11, H12, H13 and H16 and group 2 comprising
subtypes H3, H4, H7, H10, H14 and H15 [2, 49, 50]. The
number of identical amino acids in different HA subtypes
varies from 40 to 70%, and within the same subtype from
80 to 100%. In contrast, the amino acid sequences of the
bat IAV HLs are highly divergent from all known HA sub-
types derived from conventional IAVs. While both HL17
and HL18 have only 45% amino acid identity to the 16
other knownHA subtypes, they share 62% amino acid
sequence identity among each other. The primary amino
acid sequences and structure analysis of these proteins
revealed that these glycoproteins are more closely related to
group 1 than to group 2 [11, 12].
Despite the low amino acid sequence identity with conven-
tional HA, the overall structures of HLs and conventional
HAs are highly similar. The HLs also form a homotrimer
containing a membrane-proximal stem region and a mem-
brane-distal globular head, which contains the putative
receptor-binding site (RBS) [12, 14, 16]. Similar to most
conventional HA subtypes, HL17 and HL18 harbour a
monobasic cleavage site upstream of a highly conserved
stretch of hydrophobic amino acids [12, 14, 16]. At this site,
the HL proteins are cleaved by serine proteases such as tryp-
sin or human TMPRSS2, resulting in the formation of two
disulfide-linked subunits, HL1 and HL2 [51]. The proteo-
lytic cleavage of HL proteins is essential for bat IAV to be
infectious. Only following proteolytic cleavage were HL pro-
teins able to exhibit low pH-triggered membrane fusion
activity. This feature is shared by bat and conventional
IAVs and suggests that all of these viruses enter host cells by
receptor-mediated endocytosis.
The HL proteins of bat IAVs were found to mediate autono-
mous propagation of HL-pseudotyped VSV without the
need of support by NL proteins [18]. These chimeric viruses
were able to propagate in susceptible cell lines such as
canine MDCK II and bat IndFSPT cells, whereas recombi-
nant VSV expressing exclusively the NL protein in place of
VSV-G did not replicate autonomously. Interestingly, prop-
agation of chimeric VSV was not enhanced when the corre-
sponding NL protein was expressed along with HL. In
contrast, chimeric VSV expressing conventional HA was
able to propagate only if NA was expressed from the same
virus genome, in agreement with the function of NA as a
receptor-destroying enzyme [52]. The important role of HL
proteins in the entry of bat IAV was subsequently con-
firmed by neutralizing HL17NL10 and HL18NL11 infection
with antibodies specifically directed to HL17 and HL18,
respectively [18]. On the contrary, the role of NL in the bat
IAV replication cycle remains a mystery. The function of
this envelope protein obviously deviates from the classical
role of conventional NAs in virus release and dissemination.
HAEMAGGLUTININ-LIKE MOLECULES DO NOT
RECOGNIZE SIALIC ACIDS AS RECEPTOR(S)
The receptor-binding specificity of conventional HAs has
been studied in great detail. HA proteins from avian IAVs
preferentially bind to a2,3-linked sialic acids, whereas HAs
of human IAVs have a preference for sialic acids in a2,6-
linkage [53–55]. In principle, all the classical HA RBSs
consist of two parts, designated as edge and base. The edge
portion is formed by three a-helices (the 130-loop, the 190-
helix and the 220-loop) while the base portion comprises
only four conserved residues (Y98, W153, H183 and Y195),
which mediate the binding specificity of HA [56]. Intrigu-
ingly, the crystal structure of HL17 and HL18 revealed that,
in contrast to conventional HA, there is no cavity present
which could accommodate sialylated glycans. In conven-
tional IAV HA proteins, hydrogen bonds and salt bridge
networks formed by the residues D136, Q190, H226 and
D228 enable strong interactions between the a-helices of
the edge [12, 14, 16]. According to studies on the electro-
static surface potential, the putative RBS of HL is highly
acidic, making binding to negatively charged sialic acid resi-
dues unlikely. Consistently, glycan micro-array analysis
revealed no detectable binding of recombinant HL17 and
HL18 to more than 600 different glycan structures [12, 14].
All available data indicate that HL proteins recognize cellu-
lar receptor(s) that are dissimilar from sialic acid, the recep-
tor determinant for conventional IAV. Interestingly,
removal of sialic acids from cell surface glycoconjugates by
sialidase treatment somewhat enhanced the infection of
MDCK II cells by chimeric VSV-HL18, as well as by recom-
binant HL17NL10 or HL18NL11 [18]. The precise explana-
tion for this phenomenon is not known, but removal of
negatively charged sialic acids from the host cell surface
probably facilitated binding of HL proteins to the cell sur-
face by abrogating repulsion between sialic acid residues
linked to cellular receptor glycoproteins and the negatively
charged amino acids of the putative HL receptor-binding
domain. In line with this proposed mechanism, a previous
study showed that treatment of susceptible cells with tunica-
mycin, an inhibitor of N-glycosylation, reduced infection
with HL-pseudotyped VSV [57], suggesting that the
unknown cellular receptor is a glycosylated protein.
The extraordinary restricted cell tropism of chimeric VSV-
HL and recombinant bat IAV suggested that the putative
cellular receptor(s) that are recognized by HL17 and HL18
are not ubiquitously expressed. Nevertheless, they seem to
be expressed by cells from different species and tissues [18,
52, 57]. Recombinant HL17NL10 and HL18NL11 showed a
similar cell tropism suggesting that HL17 and HL18 bind to
the same or a very similar receptor. In order to gain com-
prehensive insight into the entry mechanism of bat IAVs
and to understand their extraordinary restricted cell tro-
pism, it is imperative to identify the putative receptor(s)
that mediate bat IAV binding to the host cell surface. The
knowledge of susceptible cell lines such as MDCK II and the
availability of infectious recombinant bat IAV and chimeric
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VSV-HL will undoubtedly facilitate the identification of
receptor molecules. This in turn will advance our under-
standing of the potential host range and zoonotic potential
of bat IAVs.
NEURAMINIDASE-LIKE MOLECULE OF BAT
IAVS
NA of conventional IAV exhibits sialidase (neuraminidase)
activity and catalyses the hydrolysis of the glycosidic link-
age between a sialic acid residue and the penultimate sugar
of oligosaccharides. In this way, NA destroys the receptor
determinant of conventional IAV and facilitates the release
of progeny virus. In addition, removal of sialic acid resi-
dues from the viral glycoproteins prevents virus aggrega-
tion. Finally, NA may help conventional IAV penetrate the
sialic acid-rich mucin layers covering respiratory epithelial
cells [58]. Based on phylogenetic analysis, nine subtypes of
NA are distinguished and are subdivided into two groups.
N1, N4, N5 and N8 belong to group 1 while N2, N3, N6,
N7 and N9 are members of group 2 [59]. The NA homo-
logues of bat IAV are only distantly related to the NAs of
conventional IAV. Therefore, these NAs were primarily
defined as NL10 and NL11 and were proposed to form a
new group 3 [60].
Conventional NAs are type II homotetrameric membrane
proteins with a mushroom-like conformation. The head
domain of each NA monomer consists of six topologically
b-sheets arranged in a propeller-like structure [61]. Like-
wise, the overall three-dimensional structures of NL10 and
NL11 share striking similarity with those of classical NAs
[12, 13, 15]. In addition, a calcium-binding site, which is
normally required for the stabilization of the active centrum
of conventional NAs, is highly conserved in both NL10 and
NL11. However, the crystal structures of NL10 and NL11
revealed that the conserved amino acids normally involved
in sialic acid binding are not present. Most of the amino
acid residues required for NA activity are substituted and
the putative active site is wider because the 150- and the
430-loops have been displaced. In agreement with these
observations, sialidase activity is not associated with NL10
or NL11 [12, 13, 15] and no evidence was found for binding
of NL10 or NL11 to any carbohydrate structure [12, 15].
Consequently, NL proteins might have a unique function
distinct from the known sialidase activity of canonical NAs.
The recent identification of susceptible cell lines and the
availability of reverse genetics systems for bat IAV will cer-
tainly help in identifying the function of NL proteins in the
viral life cycle.
CONCLUSIONS
Bats represent a natural reservoir for several pathogens
including Ebola virus, Hendra virus, rabies virus and SARS
and MERS coronaviruses. The identification of two new
influenza A-like viruses, HL17NL10 and HL18NL11, has
expanded the number of potentially zoonotic IAVs. This
raises important questions with respect to the origin and
evolution of IAV and poses public health concerns. Recent
findings demonstrated that the likelihood of reassortment
between conventional IAVs and bat IAVs is limited. The
inability to exchange viral RNA segments is restricted by
RNA packaging signals and a matching NP. Although the
risk of reassortment is low, the potential of adaptation to
other mammalian hosts cannot be excluded at present. The
reconstitution of synthetic HL17NL10 and HL18NL11
viruses marked a milestone in bat IAV research and allowed
for the first time the characterization of the mechanisms of
virus entry and cell tropism. Even though HL molecules
play crucial roles in bat IAV entry, the replication cycle of
bat IAVs may not follow the canonical life cycle of conven-
tional IAVs. Moreover, the ability to infect human cell lines
suggests that transmission of these viruses to the human
population is still a possibility. The use of recombinant bat
IAV for experimental infection of bats will provide deeper
insight into their tropism and transmission model in the
natural host. Importantly, identification and characteriza-
tion of cellular receptors mediating virus entry will
undoubtedly lead to clarification of the tissue tropism and
zoonotic potential of these viruses.
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